Replimune (REPL) Total Current Liabilities (2018 - 2025)

Replimune's (REPL) quarterly Total Current Liabilities came in at $50.1 million in Q4 2025, up 4.59% year-on-year from $47.9 million in Q4 2024, and down 5.32% quarter-over-quarter from $52.9 million in Q3 2025.

Replimune (REPL) Total Current Liabilities (2018 - 2025) Analysis & Trends

Replimune has disclosed Total Current Liabilities across 8 years of filings, most recently posting $50.1 million for Q4 2025.

  • Total Current Liabilities for Q4 2025 came in at $50.1 million, up 4.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $50.1 million (up 4.59% YoY), and the FY2025 annual result was $62.4 million, up 54.22% from the prior year.
  • Total Current Liabilities came in at $50.1 million for Q4 2025 at Replimune, down from $52.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $62.4 million in Q1 2025 to a low of $14.5 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $34.8 million (2023), against an average of $34.6 million.
  • Across the five-year window, Total Current Liabilities soared 69.23% in 2023 and increased 4.59% in 2025, its largest moves.
  • Replimune's Total Current Liabilities stood at $18.3 million in 2021, then surged by 44.68% to $26.5 million in 2022, then jumped by 46.05% to $38.6 million in 2023, then gained by 23.91% to $47.9 million in 2024, then climbed by 4.59% to $50.1 million in 2025.
  • The last three Total Current Liabilities figures came in at $50.1 million (Q4 2025), $52.9 million (Q3 2025), and $59.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 1.70 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 16.35 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 636.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 13.42 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.71 Bn 91.71 Bn - 72.86 Mn
10 Replimune 780.01 Mn 510.88 Mn - 50.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 50.09 Mn
Sep 30, 2025 52.90 Mn
Jun 30, 2025 59.56 Mn
Mar 31, 2025 62.36 Mn
Dec 31, 2024 47.89 Mn
Sep 30, 2024 43.79 Mn
Jun 30, 2024 35.68 Mn
Mar 31, 2024 40.44 Mn
Dec 31, 2023 38.65 Mn
Sep 30, 2023 39.83 Mn
Jun 30, 2023 32.24 Mn
Mar 31, 2023 33.83 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 23.54 Mn
Jun 30, 2022 20.31 Mn
Mar 31, 2022 20.76 Mn
Dec 31, 2021 18.29 Mn
Sep 30, 2021 16.64 Mn
Jun 30, 2021 15.05 Mn
Mar 31, 2021 14.55 Mn